Trade

Acutaas Chemicals share price

Balanced risk
  • 37%Low risk
  • 37%Moderate risk
  • 37%Balanced risk
  • 37%High risk
  • 37%Extreme risk
  • ₹1,705.00(-0.36%)
    December 5, 2025 15:29:20 PM IST
    • NSE
    • BSE
  • Vol : 124.61 K (NSE + BSE)
    Last 20 day avg : 341.68 K

Acutaas Chemicals is trading -0.36% lower at Rs 1,705.00 as compared to its last closing price. Acutaas Chemicals has been trading in the price range of 1,725.85 & 1,686.70. Acutaas Chemicals has given 59.08% in this year & -4.44% in the last 5 days. Acutaas Chemicals has TTM P/E ratio 48.16 as compared to the sector P/E of 32.51.There are 6 analysts who have initiated coverage on Acutaas Chemicals. There are 2 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 72.24 Crores in its last quarter.Listed peers of Acutaas Chemicals include SRF (1.45%), Solar Industries India (-0.72%), Coromandel International (-0.80%).The Mutual Fund holding in Acutaas Chemicals was at 15.81% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Acutaas Chemicals was at 16.84% in 30 Sep 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Dec 06, 2025, 07:15 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.03
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.01
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.09
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    10.68
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    62.46
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    2.66
    Indicates overvaluation
Price range
Day Range
Lowest
1,686.70
Highest
1,725.85
52 week range
Lowest
919.63
Highest
1,901.35
Acutaas Chemicals News
Acutaas Chemicals Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
SRF
Neutral
2,882.001.4585,429.6367.086.670.2716.14
Solar Industries India
Bearish
12,847.35-0.721,16,255.7493.5526.70.089.52
Coromandel International
Neutral
2,281.10-0.8067,227.6837.576.110.525.40
Pidilite Industries
Bearish
1,472.45-0.831,49,853.3072.0215.480.672.26
Asian Paints
Bullish
2,967.150.342,84,815.4472.2014.610.857.13
Mutual Fund Ownership
View all
SBI Healthcare Opportunities Fund Regular Growth
NA
  • Amount Invested (Cr.) 117.63
  • % of AUM 3.19
Kotak Consumption Fund Regular Growth
NA
  • Amount Invested (Cr.) 36.64
  • % of AUM 2.94
Bank of India ELSS Tax Saver Fund Eco Growth
4/5
  • Amount Invested (Cr.) 37.39
  • % of AUM 2.67
Bank of India ELSS Tax Saver Fund Regular Growth
4/5
  • Amount Invested (Cr.) 37.39
  • % of AUM 2.67
Kotak Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 10.59
  • % of AUM 2.44
Acutaas Chemicals Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-10-17Quarterly Results
2025-07-30Quarterly Results
2025-05-02Audited Results & Final Dividend
2025-02-21Stock Split
2025-01-28Quarterly Results
About the company Acutaas Chemicals
  • IndustryChemical Manufacturing
  • ISININE00FF01025
  • BSE Code543349
  • NSE CodeACUTAAS
Acutaas Chemicals Limited, formerly Ami Organics Limited, is a manufacturer of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 520 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.
  • Management Info
  • Nareshkumar PatelExecutive Chairman of the Board and Managing Director
  • Bhavin ShahChief Financial Officer
  • Chetansinh ParmarChief Information Security Officer
  • Ekta SrivastavaCompany Secretary and Compliance Officer
  • Ram LokhandeWhole Time Director
  • Virendra MishraWhole Time Director
  • Chetankumar VaghasiaWhole Time Director
Acutaas Chemicals Share Price FAQs

Acutaas Chemicals is trading at 1705.00 as on Fri Dec 05 2025 09:59:20. This is -0.36% lower as compared to its previous closing price of 1711.10.

The market capitalization of Acutaas Chemicals is 13977.82 Cr as on Fri Dec 05 2025 09:59:20.

The average broker rating on Acutaas Chemicals is Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 3 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Acutaas Chemicals is 1901.35 whereas the 52 wk low is 919.63

Acutaas Chemicals can be analyzed on the following key metrics -

  • TTM P/E: 48.16
  • Sector P/E: 32.51
  • Dividend Yield: 0.09%
  • D/E ratio: 0.01

Acutaas Chemicals reported a net profit of 158.71 Cr in 2025.

The Mutual Fund Shareholding was 15.81% at the end of 30 Sep 2025.

Quick Links
EQUITY QUICK LINKS
Acutaas Chemicals QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Business News/Market/Market Stats/  Acutaas Chemicals share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.